IUGNF - Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
(NewsDirect)
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactiveit has been a busy and productive start to the new year with a numberof presentations including at the JP Morgan Healthcare Conference. Thecompany also presented an oral abstract and several poster sessions onits HER-Vaxx and CF33 technologies at the ASCO GastrointestinalCancers Symposium in the US.
ContactDetails
Proactive Investors
JonathanJackson
+61 413 713 744
Jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.